Peter Langguth

13.8k total citations · 1 hit paper
271 papers, 9.1k citations indexed

About

Peter Langguth is a scholar working on Pharmaceutical Science, Oncology and Molecular Biology. According to data from OpenAlex, Peter Langguth has authored 271 papers receiving a total of 9.1k indexed citations (citations by other indexed papers that have themselves been cited), including 127 papers in Pharmaceutical Science, 60 papers in Oncology and 56 papers in Molecular Biology. Recurrent topics in Peter Langguth's work include Drug Solubulity and Delivery Systems (108 papers), Drug Transport and Resistance Mechanisms (56 papers) and Advanced Drug Delivery Systems (48 papers). Peter Langguth is often cited by papers focused on Drug Solubulity and Delivery Systems (108 papers), Drug Transport and Resistance Mechanisms (56 papers) and Advanced Drug Delivery Systems (48 papers). Peter Langguth collaborates with scholars based in Germany, United States and Sweden. Peter Langguth's co-authors include Gordon L. Amidon, Hildegard Spahn‐Langguth, H. Spahn‐Langguth, Hans P. Merkle, Thomas Nawroth, C G Regårdh, Siegfried Wolffram, Jozef Al-Gousous, Constanze Hilgendorf and Abeer Hanafy and has published in prestigious journals such as Advanced Materials, Angewandte Chemie International Edition and SHILAP Revista de lepidopterología.

In The Last Decade

Peter Langguth

268 papers receiving 8.9k citations

Hit Papers

A comparative study of th... 2011 2026 2016 2021 2011 50 100 150 200

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Peter Langguth 3.3k 2.2k 1.9k 1.0k 954 271 9.1k
James E. Polli 2.6k 0.8× 1.5k 0.7× 2.0k 1.1× 837 0.8× 1.2k 1.2× 198 7.0k
Shinji Yamashita 2.9k 0.9× 1.4k 0.6× 1.6k 0.8× 862 0.8× 665 0.7× 167 5.8k
Valentino J. Stella 3.1k 1.0× 2.7k 1.2× 1.2k 0.7× 1.1k 1.0× 594 0.6× 185 9.0k
René Holm 4.7k 1.4× 1.9k 0.8× 1.1k 0.6× 1.9k 1.9× 680 0.7× 266 8.3k
Pieter Annaert 1.9k 0.6× 1.3k 0.6× 1.9k 1.0× 1.1k 1.1× 1.4k 1.4× 237 7.6k
Anette Müllertz 7.3k 2.2× 2.1k 1.0× 1.7k 0.9× 2.1k 2.0× 865 0.9× 274 11.2k
Werner Weitschies 3.3k 1.0× 1.3k 0.6× 936 0.5× 1.0k 1.0× 707 0.7× 270 9.2k
Arik Dahan 3.3k 1.0× 1.3k 0.6× 1.9k 1.0× 945 0.9× 604 0.6× 135 6.6k
Christel A. S. Bergström 2.8k 0.9× 1.3k 0.6× 1.3k 0.7× 1.8k 1.8× 620 0.6× 149 6.5k
William N. Charman 7.4k 2.2× 3.6k 1.6× 2.6k 1.4× 1.8k 1.8× 1.1k 1.1× 170 14.8k

Countries citing papers authored by Peter Langguth

Since Specialization
Citations

This map shows the geographic impact of Peter Langguth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Langguth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Langguth more than expected).

Fields of papers citing papers by Peter Langguth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Langguth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Langguth. The network helps show where Peter Langguth may publish in the future.

Co-authorship network of co-authors of Peter Langguth

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Langguth. A scholar is included among the top collaborators of Peter Langguth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Langguth. Peter Langguth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vela, Stefano Da, Daniel Franke, Dmytro Soloviov, et al.. (2025). AF4-to-SAXS: expanded characterization of nanoparticles and proteins at the P12 BioSAXS beamline. Journal of Synchrotron Radiation. 32(4). 971–985. 1 indexed citations
2.
Graewert, Melissa A., et al.. (2025). Direct structural investigation of pH responsiveness in mRNA lipid nanoparticles: Refining paradigms. Journal of Controlled Release. 384. 113848–113848. 3 indexed citations
3.
Wachtel, Herbert, et al.. (2024). Aerosol Plumes of Inhalers Used in COPD. Pulmonary Therapy. 10(1). 109–122. 1 indexed citations
4.
Abrahamsson, Bertil, Naseem A. Charoo, Rodrigo Cristofoletti, et al.. (2024). Biowaiver monographs for immediate-release solid oral dosage forms: Voriconazole. Journal of Pharmaceutical Sciences. 114(2). 660–680. 4 indexed citations
5.
Koning, Roman I., Melissa A. Graewert, Bert Wouters, et al.. (2024). On the Influence of Fabrication Methods and Materials for mRNA‐LNP Production: From Size and Morphology to Internal Structure and mRNA Delivery Performance In Vitro and In Vivo. Advanced Healthcare Materials. 13(26). e2401252–e2401252. 9 indexed citations
6.
Al-Gousous, Jozef, et al.. (2024). Solubility vs Dissolution in Physiological Bicarbonate Buffer. Pharmaceutical Research. 41(5). 937–945. 8 indexed citations
7.
Stein, Lara, et al.. (2024). Microneedle-enhanced drug delivery: fabrication, characterization, and insights into release and permeation of nanocrystalline imiquimod. SHILAP Revista de lepidopterología. 4. 1425144–1425144. 3 indexed citations
8.
Schroer, Martin A., Daniel Franke, Thomas Nawroth, et al.. (2023). Polysarcosine-Functionalized mRNA Lipid Nanoparticles Tailored for Immunotherapy. Pharmaceutics. 15(8). 2068–2068. 23 indexed citations
9.
Stein, Lara, Danielle Arnold-Schild, Matthias Klein, et al.. (2023). Tumor-infiltrating CCR2+ inflammatory monocytes counteract specific immunotherapy. Frontiers in Immunology. 14. 1267866–1267866. 3 indexed citations
10.
Graewert, Melissa A., Clément Blanchet, Florian Meier, et al.. (2023). Quantitative size-resolved characterization of mRNA nanoparticles by in-line coupling of asymmetrical-flow field-flow fractionation with small angle X-ray scattering. Scientific Reports. 13(1). 15764–15764. 28 indexed citations
11.
Varum, Felipe, et al.. (2022). In Vitro Methodologies for Evaluating Colon-Targeted Pharmaceutical Products and Industry Perspectives for Their Applications. Pharmaceutics. 14(2). 291–291. 22 indexed citations
12.
Taraban, Marc B., Dajun Sun, Jason D. Rodriguez, et al.. (2021). Evaluation of the Physicochemical Properties of the Iron Nanoparticle Drug Products: Brand and Generic Sodium Ferric Gluconate. Molecular Pharmaceutics. 18(4). 1544–1557. 7 indexed citations
13.
Augustijns, Patrick, Maria Vertzoni, Christos Reppas, et al.. (2020). Unraveling the behavior of oral drug products inside the human gastrointestinal tract using the aspiration technique: History, methodology and applications. European Journal of Pharmaceutical Sciences. 155. 105517–105517. 22 indexed citations
14.
Al-Gousous, Jozef, Niloufar Salehi, Gregory E. Amidon, et al.. (2019). Mass Transport Analysis of Bicarbonate Buffer: Effect of the CO2–H2CO3 Hydration–Dehydration Kinetics in the Fluid Boundary Layer and the Apparent Effective pKa Controlling Dissolution of Acids and Bases. Molecular Pharmaceutics. 16(6). 2626–2635. 47 indexed citations
15.
Lopez, Pamela Aranda, Peter Langguth, Hideo Yagita∥, et al.. (2019). Transcutaneous immunization with CD40 ligation boosts cytotoxic T lymphocyte mediated antitumor immunity independent of CD4 helper cells in mice. European Journal of Immunology. 49(11). 2083–2094. 9 indexed citations
16.
Griffin, Brendan T., et al.. (2018). Exploring gastric emptying rate in minipigs: Effect of food type and pre-dosing of metoclopramide. European Journal of Pharmaceutical Sciences. 118. 183–190. 15 indexed citations
17.
Al-Gousous, Jozef, Daniel P. McNamara, Bart Hens, et al.. (2018). Mass Transport Analysis of the Enhanced Buffer Capacity of the Bicarbonate–CO2 Buffer in a Phase-Heterogenous System: Physiological and Pharmaceutical Significance. Molecular Pharmaceutics. 15(11). 5291–5301. 32 indexed citations
18.
Tsume, Yasuhiro, et al.. (2014). The Biopharmaceutics Classification System: Subclasses for in vivo predictive dissolution (IPD) methodology and IVIVC. European Journal of Pharmaceutical Sciences. 57. 152–163. 254 indexed citations
19.
Taki, Yoko, Toshiyasu Sakane, TANEKAZU NADAI, et al.. (1995). Gastrointestinal absorption of peptide drug: quantitative evaluation of the degradation and the permeation of metkephamid in rat small intestine.. Journal of Pharmacology and Experimental Therapeutics. 274(1). 373–377. 18 indexed citations
20.
Langguth, Peter, et al.. (1991). Studies on the stability of aspartame 1 specific and reproducible hplc assay for aspartame and its potential degradation products and applications to acid hydrolysis of aspartame. Pharmazie. 46(3). 188–192. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026